These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24285344)

  • 41. In vitro cytochrome P450- and transporter-mediated drug interaction potential of 6β-hydroxy-21-desacetyl deflazacort-A major human metabolite of deflazacort.
    Ma J; Beers B; Manohar R; Roe S; Colacino JM; Kong R
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00748. PubMed ID: 33749127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
    Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
    Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.
    Jin HE; Song B; Kim SB; Shim WS; Kim DD; Chong S; Chung SJ; Shim CK
    Xenobiotica; 2013 Apr; 43(4):355-67. PubMed ID: 23020787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions.
    Székely V; Patik I; Ungvári O; Telbisz Á; Szakács G; Bakos É; Özvegy-Laczka C
    Eur J Pharm Sci; 2020 Aug; 151():105395. PubMed ID: 32473861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ochratoxin A transport by the human breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), and organic anion-transporting polypeptides 1A2, 1B1 and 2B1.
    Qi X; Wagenaar E; Xu W; Huang K; Schinkel AH
    Toxicol Appl Pharmacol; 2017 Aug; 329():18-25. PubMed ID: 28532671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
    Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
    Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Saturation of multidrug-resistant protein 2 (mrp2/abcc2)-mediated hepatobiliary secretion: nonlinear pharmacokinetics of a heterocyclic compound in rats after intravenous bolus administration.
    Hu Y; Sampson KE; Heyde BR; Mandrell KM; Li N; Zutshi A; Lai Y
    Drug Metab Dispos; 2009 Apr; 37(4):841-6. PubMed ID: 19139164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide.
    Hoffmaster KA; Turncliff RZ; LeCluyse EL; Kim RB; Meier PJ; Brouwer KL
    Pharm Res; 2004 Jul; 21(7):1294-302. PubMed ID: 15290872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
    Su Y; Zhang X; Sinko PJ
    Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
    Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
    Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
    Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
    Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3.
    Ikema S; Takumi S; Maeda Y; Kurimoto T; Bohda S; Chigwechokha PK; Sugiyama Y; Shiozaki K; Furukawa T; Komatsu M
    Food Chem Toxicol; 2015 Sep; 83():229-36. PubMed ID: 26134461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
    Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
    J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
    Ebner T; Ishiguro N; Taub ME
    J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro evaluation of potential transporter-mediated drug interactions of evogliptin.
    Lee DY; Chae HW; Shim HJ
    Biopharm Drug Dispos; 2017 Sep; 38(6):398-403. PubMed ID: 28503751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.
    Patel M; Sheng Y; Mandava NK; Pal D; Mitra AK
    Int J Pharm; 2014 Dec; 476(1-2):99-107. PubMed ID: 25261710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line.
    Fahrmayr C; König J; Auge D; Mieth M; Münch K; Segrestaa J; Pfeifer T; Treiber A; Fromm M
    Br J Pharmacol; 2013 May; 169(1):21-33. PubMed ID: 23387445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.
    Shitara Y; Takeuchi K; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Pharmacokinet; 2012; 27(4):368-78. PubMed ID: 22240838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition.
    Mikkaichi T; Yoshigae Y; Masumoto H; Imaoka T; Rozehnal V; Fischer T; Okudaira N; Izumi T
    Drug Metab Dispos; 2014 Apr; 42(4):520-8. PubMed ID: 24459178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.